Effective Factors on Auditory Brainstem Response Test in Newborns
Mozafar sarafraz, Maryam Kardooni and Somayeh Araghi*
Associated professor of otolaryngology, Head and neck surgery, Hearing & Speech Research Centre , Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
DOI : http://dx.doi.org/10.13005/bbra/1935
ABSTRACT: Aim Promotion of community health careis one of the major health and treatment policies. In this regard, prevention is considered the primary, most important and effective level of health care. Given the high prevalence of congenital (sensorineural) hearing loss (nearly 1/1000 to 3/1000 of live births) large numbers of neonates with congenital hearing loss will be born annually. Hearing loss will cause adverse effects on social, cognitive and speech development of these children. Therefore, early, even neonatal, diagnosis and treatment of hearing loss has been recommended in order to prevent such complications. This study has been conducted with the aim of hearing screening of the newborns and evaluating the effective factors on Auditory Brainstem Response (ABR) test. In this descriptive study all included newborns were examined by TEOAE test during first week after birth. The result of the test was interpreted as "Pass" or "Refer". In case of "Refer", the test was repeated 3 weeks later. In neonates with the test result of "refer" in the second step, the ABR was done.The following risk factors were evaluated:
- History of NICU admission for more than 48 hours
- History of neonatal exchange transfusion
- Family history of hearing deficiency
- Birth weight
- Administration of aminoglycosides in neonatal period.
- History of NICU admission for more than 48 hours was positive in 4.8% of normal newborns but in 55% of neonates with abnormal ABR test, and the difference was significant (P<0.001).
- Family history of hearing deficiency was positive in 4.4% of normal newborns but 5.9% of neonates with abnormal ABR test, so there was not a significant relation (P=0.191).
- Low birth weight (<1500 gr) was found in 1.5% of normal newborns and 11.5% of neonates with abnormal ABR test, and the relation was statistically significant (P<0.001).
- History of neonatal exchange transfusion was present in 2.8% of normal newborns but 2.1% of neonates with abnormal ABR test, so there was not a significant relation (P=0.563)
- Administration of aminoglycosides in neonatal period was present in 2% of normal newborns but20% neonates with abnormal ABR test, which were significantly different (P<0.001).
- The results showed a significant relation between abnormal ABR test and history of NICU admission for more than 48 hours, low birth weight and administration of aminoglycosides in neonatal period.
KEYWORDS: hearing screening; congenital hearing loss; Auditory Brainstem Response; neonate
Download this article as:Copy the following to cite this article: Sarafraz M, Kardooni M, Araghi S. Effective Factors on Auditory Brainstem Response Test in Newborns. Biosci Biotechnol Res Asia 2015;12(3) |
Copy the following to cite this URL: Sarafraz M, Kardooni M, Araghi S. Effective Factors on Auditory Brainstem Response Test in Newborns. Biosci Biotechnol Res Asia 2015;12(3). Available from: https://www.biotech-asia.org/?p=3988 |